Ralf, Arwin http://orcid.org/0000-0001-6052-0807
Montiel González, Diego
Zandstra, Dion http://orcid.org/0000-0002-2197-6315
van Wersch, Bram
Kousouri, Nefeli
de Knijff, Peter http://orcid.org/0000-0002-0899-771X
Adnan, Atif http://orcid.org/0000-0003-4537-0059
Claerhout, Sofie http://orcid.org/0000-0003-0857-0211
Ghanbari, Mohsen http://orcid.org/0000-0002-9476-7143
Larmuseau, Maarten H. D. http://orcid.org/0000-0002-5974-7235
Kayser, Manfred http://orcid.org/0000-0002-4958-847X
Article History
Received: 29 July 2022
Accepted: 26 September 2022
First Online: 3 October 2022
Declarations
:
: MK and AR are inventors of a filed patent application: No. EP20158807 (“Novel Y-chromosomal short tandem repeat markers for typing male individuals) but receive no license fees or royalties from this.
: The Medical Ethics Committee of the Erasmus MC allowed the execution of the present study within the Erasmus MC (MEC-2020-0535). The samples included in Cohort 1 were collected in the context of the Erasmus Rucphen Family study (Sayed-Tabatabaei et al. CitationRef removed). The Erasmus Rucphen Family study protocol was approved by the Medical Ethics Committee of the Erasmus MC Rotterdam, the Netherlands (MEC 213.575/2002/114). In accordance with the Declaration of Helsinki, the Erasmus Rucphen Family study obtained informed consent from all participants prior to their entering the study. The Medical Ethics committee at KU Leuven/UZ Leuven allowed broad Y-STR analyses of the patrilineal relatives (S55864; S59085; S54010) from Cohort 2, participants provided informed consent. The Ethics board from University of Health Sciences Lahore Pakistan approved the collection of the samples from Cohort 3 (UHS/Education/126-13/2390), which were all collected under informed consent.
: Informed consent was obtained from all individual participants included in the study.
: No personal data of any of the individual participants is made publically available in this study.